- Show all
- Abigail Coursolle
- Alejandra Pavisich
- Alejandra Pavisich
- Alexis Robles-Fradet
- Alicia Emanuel
- Amanda Avery
- Amy Chen
- Andy DiAntonio
- Arielle Linsey
- Brian Brooks
- Candace Gibson
- Carly Myers
- Cassandra LaRose
- Cat Duffy
- Catherine McKee
- Cathren Cohen
- Charlie Blodnieks
- Charly Gilfoil
- Cheyenne Peters
- Christina Piecora
- Corey Davis
- Dania Douglas
- Daniel Young
- David Machledt
- Deanna Hartog
- Elizabeth Edwards
- Elizabeth G. Taylor
- Emma Parker-Newton
- Eskedar Girmash
- Fabiola De Liban
- Georgesula Ziama
- Geron Gadd
- Hannah Eichner
- Hayley Penan
- Héctor Hernández-Delgado
- Ian McDonald
- Jane Perkins
- Jasmine Young
- Jennifer Lav
- Joe McLean
- Jules Lutaba
- Kally Xu
- Kasey Nichols
- Kavisha Prajapati
- Kimberly Lewis
- Leonardo Cuello
- lhigashi
- Liz McCaman Taylor
- Madeline Morcelle
- Mara Youdelman
- Margaret Okakpu
- Maya Levin
- Michelle Lilienfeld
- Michelle Yiu
- Miriam Delaney Heard
- Mizue Suito
- Priscilla Huang
- Rachel Holtzman
- Rolonda Donelson
- Sarah Grusin
- Sarah Somers
- Skyler Rosellini
- Susan Berke Fogel
- T. Nancy Lam
- veng
- Walter Hsiang, MD
- Wayne Turner
- Zamir M. Brown
- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- April 3, 2023
NHeLP Comments on the DEA Buprenorphine via Telemedicine Proposed Rule
Read moreIn these comments on the Buprenorphine via Telemedicine Proposed Rule, NHeLP urges the DEA to withdraw the proposed rule related to the induction of buprenorphine via telemedicine and continue the expanded telemedicine flexibilities under the Opioid Public Health Emergency.
- March 31, 2023
[Video] Issue -Spotting During the Medicaid Unwinding
National Health Law Program (NHeLP) VideoRead moreIn this new video, we discuss some major issues people might encounter during the nationwide Medicaid unwinding process. The video provides a high-level overview of the unwinding process. It gives advocates and community members the information they need to help individuals and families navigate Medicaid renewals. This video breaks…
- October 18, 2022
Model Contraceptive Equity Act: Legislative Language and Issue Brief
Read moreUpdated October 2023. This paper begins with model legislative language that can serve as a template for state advocates seeking to expand contraceptive coverage. The paper concludes with an issue brief explaining the provisions within the Model Contraceptive Equity Act and how they advance equitable access to contraceptive services…
- September 6, 2022
NHeLP Letter to Congressional Leadership – Re: The Mainstreaming Addiction Treatment Act (“MAT Act”, S. 445 / H.R. 1384)
Read moreSeptember is Recovery Month — a month to honor the more than 20 million Americans in recovery from substance use disorder (SUD). Evidence-based treatment is the first step toward recovery, and medications for opioid use disorder (MOUD) are proven to significantly reduce the risk of overdose and support those…
- July 28, 2022
California Prepares for PHE Unwinding through Release of Operational Plan
Read moreCOVID-19 Public Health Emergency (PHE). While not required, CMS has encouraged states to make their plans publicly available. In their latest guidance to states, CMS outlines detailed requirements and recommendations for states to effectively return to normal business operations when the PHE ends. In May, California’s Medicaid agency, Department…
- May 16, 2022
Medicaid Coverage of Advanced Practice Prescribing for Reproductive & Sexual Health Medications
Read moreAdvanced practice providers (APPs) are licensed health care practitioners, other than physicians, who may practice independently and bill directly under state law. Public health research supports making a variety of reproductive and sexual health medications available through APPs. There are two primary state policy levers that impact access to…
